5-Azacytidine (NSC 102816) in refractory germ cell tumors - A phase II trial of the Eastern Cooperative Oncology Group

Bruce J. Roth, Paul Elson, George W. Sledge, Lawrence H. Einhorn, Donald L. Trump

Research output: Contribution to journalArticlepeer-review

18 Scopus citations
Original languageEnglish (US)
Pages (from-to)201-202
Number of pages2
JournalInvestigational New Drugs
Volume11
Issue number2-3
DOIs
StatePublished - Jun 1993

Keywords

  • 5-azacytidine
  • cisplatin-refractory
  • germ cell tumors
  • testicular cancer

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this